Spain to Legalize Medical Plants Sales This Year
Spain is likely to join the growing list of countries that treat plants as medicine and allow the drug to be sold to patients with certain conditions. The initiative to create a legal and regulated market has moved out of a congressional subcommittee and is expected to be approved by the Health Commission on Thursday. After this final vote, it will be up to the Spanish Medicines Agency to draw up regulations and set up a system for the legal sales of the drug through pharmacies within the next six months.
The country has one of the world’s most lax plants policies, with Barcelona – and not Amsterdam – emerging as Europe’s new plants capital. However, the laws trail behind the lenient attitude of the Spanish society toward the drug, and there’s a need for a more robust regulatory framework.
The List of Conditions is Limited but Can be Extended
It’s not yet clear what type of doctors will be able to prescribe plants medicine to their patients and whether other therapeutic options will have to be exhausted first. However, the draft bill clearly states which conditions are eligible to be treated with plants pharmaceuticals. They include pain management in cancer and non-cancer patients, chemotherapy-induced nausea and vomiting, multiple sclerosis, as well as endometriosis and some forms of epilepsy.
The bill suggests that as long as there’s scientific evidence to support the claim, other indtions can be added to this list.
A Broad Political Support for the Reform
According to Carola Pérez, the president of the Spanish Observatory for Medicinal Plants and founder of the patient association dosemociones, the authors of the initiative had to struggle for every clause and every medical condition to be included in the final draft. However, the support for the reform is undeniable and includes backing from most parties except for right-leaning PP and Vox.
Campaigners and activists see the move as a sign of impending further liberalization of plants laws in Spain. However, the bill highlights the need for safeguards that will prevent plants medicine from seeping into the black market and increasing the use of the drug by the healthy part of the population.
Comments